Advanced Filters
noise

Taipei County, Taiwan Clinical Trials

A listing of Taipei County, Taiwan clinical trials actively recruiting patients volunteers.

Found 981 clinical trials
S Shu-mei Yang, MD

SURE Trial: Swallowing Ultrasound Reliability Evaluation Trial

This study aims to explore the reliability of using ultrasonography (US) for the assessment of swallowing function in patients with dysphagia. The study will recruit 80 patients and compare the findings with those obtained from fiberoptic endoscopic evaluation of swallowing (FEES), which serves as the gold standard.

18 years of age All Phase N/A
S Shu-Yu Liu

Development of Biomarkers for Monitoring Menopause in Women

This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative …

20 years of age Female Phase N/A
W WEN-HUI FANG, Ph. D.

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

20 years of age All Phase N/A

Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation

Currently, the literature regarding the relationship between Pulse Wave Velocity (PWV) and functional recovery, particularly of upper limb function, in patients with subacute stroke is still limited. Therefore, the aim of the study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation …

18 - 80 years of age All Phase N/A
C CHIAWEN LU, ASSOCIATED PROFESSOR

A Wearable Device and AI-Supported Diet and Exercise Intervention

This study implemented a personalized 6-month diet and exercise program to promote weight loss. Participants were recruited from outpatient clinics at the Department of Family Medicine, National Taiwan University Hospital. Overweight and obese adults were eligible, defined as follows: overweight (BMI 24-27 kg/m²), mild obesity (BMI 27-30 kg/m²), moderate obesity …

20 years of age All Phase N/A

Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma

The goal of this clinical trial is to investigate the efficacy and safety of sacituzumab govitecan in patients with advanced esophageal squamous cell carcinoma.

18 years of age All Phase 2

Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients

To evaluate patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery

20 years of age All Phase N/A
S Shwu-Fen Wang Director

Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease

People with Parkinson's disease have been known to have low motivation and motor learning impairment, which might limit the effectiveness of neurorehabilitation, exacerbate motor performance and quality of life, and increase the burden on caregivers. Therefore, enhancing motor learning ability and motivation is crucial for people with PD. According to …

20 years of age All Phase N/A

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Primary Objectives In phase 1b cohort, to determine MTD (maximum tolerated dose) of nal-IRI (ONIVYDE®) in combination with Ramucirumab (Cyramza®) and TAS-102 (LONSURF®) In phase II cohort, to evaluate disease objective response rate (ORR) of Ramucirumab (Cyramza®), nal-IRI (ONIVYDE®) in combination with TAS-102 (LONSURF®) Secondary Objectives To evaluate disease control …

20 - 80 years of age All Phase 1/2

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

This is a 3-part study. Phase 1a (dose escalation) is designed to assess the safety and tolerability and to determine the maximum tolerated dose (MTD) and putative recommended phase 2 dose (RP2D) of study drug as monotherapy. Phase 1b (Cohort Expansion) is intended to further characterize the safety and preliminary …

18 years of age All Phase 1/2

Simplify language using AI